Design Therapeutics, Inc. (NASDAQ:DSGN) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five brokerages that are presently covering the company, MarketBeat.com...